Search Within

Isabel Ruth Preeshagul

Formats
  1. Journal Article (17)
  2. Meeting Abstract (17)
  3. Editorial (3)
  4. Guidelines (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (39)
  2. Solid Tumor Oncology Division (39)
  3. Thoracic Oncology (39)
  4. Weinberg Fellows (24)
  5. Department of Pathology and Laboratory Medicine (17)
  6. GSK Faculty (17)

More Groups

People
  1. Matthew Hellmann (14)
  2. Mark Kris (12)
  3. Daniel Gomez (11)
  4. Hira Rizvi (11)
  5. Jamie Chaft (11)
  6. Andreas Rimner (10)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (3)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Journal of Thoracic Oncology (6)
  3. Clinical Cancer Research (4)
  4. International Journal of Radiation Oncology, Biology, Physics (4)
  5. Radiotherapy and Oncology (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (14)
  2. American Society of Clinical Oncology (8)
  3. American Association for Cancer Research (5)
  4. Future Medicine (2)
  5. AME Publishing Company (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Addressing clinical trial barriers in lung cancer: Patient-reported impact of resources on trial participation
    Meeting Abstract

    Preeshagul, I. R.; Das, D. G.; Arfe, A.; Awad, M. M.; Feldman, J. L.; Conneran, T.; Horn, M. K.; Singhi, E. K.; Daly, R. M.; Wozniak, A. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Patient-reported experience with an immunotherapy telehealth platform
    Meeting Abstract

    Daly, R. M.; Malling, C.; Dagostino, A.; Bange, E. M.; Preeshagul, I. R.; Aggen, D. H.; Carlo, M.; Chen, M. F.; Eng, J.; Ng, K. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Order of treatment with ALK inhibitors and its effect on people with lung cancer in the real world: A plain language summary
    Editorial

    Bauman, J. R.; Liu, G.; Preeshagul, I.; Melosky, B.; Abrahami, D.; Li, B.; Thomaidou, D.; Krulewicz, S.; Rupp, M.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Things you should know about managing ALK plus metastatic NSCLC
    Editorial

    Kris, M. G.; Gainor, J.; Preeshagul, I.; Yu, H. A.
    Oncology (Norwalk) (2025)

    Fulltext@MSK | Save
  • Prospective evaluation of a single-day multidisciplinary clinic for patients with locally advanced non-small cell lung cancer
    Meeting Abstract

    Billing, D. L.; Chaft, J. E.; Jones, D. R.; Daly, R.; Schoenfeld, A. J.; Mueller, B. A.; Preeshagul, I.; Park, B. J.; Iyengar, P.; Gomez, D. R.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC
    Meeting Abstract

    Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Optimizing clinical research in a regional cancer center network: A survey-based approach
    Meeting Abstract

    Preeshagul, I. R.; Syldor, A.; Terzulli, S. L.; Gordon, R. A.; Evans, L. A.; Moran, S.; Eng, J.; Daly, R. M.; Rao, D.; Momtaz, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer
    Journal Article

    Bauman, J. R.; Liu, G.; Preeshagul, I.; Liu, S. V.; Melosky, B.; Abrahami, D.; Li, B.; Thomaidou, D.; Duncan, K.; Krulewicz, S.; more...
    Lung Cancer (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save